Best peptides for Metabolic

GLP-1 receptor agonist | Type 2 diabetes and obesity

### Semaglutide Summary Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that has been investigated for its role in managing type 2 diabetes and obesity. Its efficacy in promoting weight loss and improving glycemic control has garnered significant attention in recent clinical research.

Essential Cellular Coenzyme & Anti-Aging Therapy

### Summary NAD+ (Nicotinamide adenine dinucleotide) is a crucial coenzyme involved in various metabolic processes, including energy production and cellular repair mechanisms. Recent research highlights its potential roles in protecting against oxidative stress and enhancing therapeutic efficacy in certain cancer treatments.

Mitochondrial-Targeted Peptide | Cardiolipin Protector

### Summary SS-31, also known as Elamipretide, is a peptide that has garnered attention for its potential role in mitochondrial protection and its implications in various health conditions, particularly those involving oxidative stress and mitochondrial dysfunction.

Metabolic regulation | Vascular health

### Summary PE 22-28 is a peptide that has garnered attention in various research contexts, particularly in relation to vascular health and metabolic conditions. Its potential implications in gestational diabetes and placental function are areas of ongoing investigation.

GIP/GLP-1 Agonist | Type 2 Diabetes and Obesity

### Summary Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that has been investigated for its potential in managing type 2 diabetes and obesity. Its unique mechanism of action aims to enhance glycemic control and promote weight loss.

EPO | Red Blood Cell Stimulating Hormone

Erythropoietin (EPO) is a glycoprotein hormone that stimulates red blood cell production in bone marrow, used clinically for anemia and studied in hematology and metabolic research.

Mitochondrial-Derived Peptide | Metabolic Regulator

### Summary MOTS-C is a mitochondrial-derived peptide that has garnered attention for its potential roles in metabolic regulation and cellular stress responses. Emerging research suggests it may have implications in various health conditions, including cardiovascular diseases and placental function.

Stimulates GLP-1 secretion | Appetite regulation

### Summary GLP-1 blends refer to combinations of glucagon-like peptide-1 (GLP-1) analogs or related compounds that may enhance the secretion of this hormone, which plays a critical role in glucose metabolism and appetite regulation. Recent research has explored various natural extracts and dietary components that may influence GLP-1 secretion and its physiological effects.

Gene expression modulation | Liver support

Ovagen (EDL) is a Khavinson-family tripeptide bioregulator researched for liver and gastrointestinal tissue support, proposed to act via gene-expression modulation in hepatocytes and enterocytes.

Triple reuptake inhibitor | Weight management

### Summary Tesofensine is a novel compound initially developed as an antidepressant, which has gained attention for its potential effects on weight loss and metabolic regulation. Research indicates that it may influence neurotransmitter levels, thereby affecting appetite and energy expenditure.

Mitochondrial uncoupler | Obesity treatment

BAM-15 is a mitochondrial protonophore uncoupler studied preclinically for obesity, insulin resistance, and metabolic dysfunction by increasing energy expenditure without raising heart rate.

Long-Acting Amylin Receptor Agonist | Weight Loss & Diabetes

Cagrilintide (AM833) is a long-acting amylin analog investigated for once-weekly subcutaneous use in obesity and type 2 diabetes, most notably combined with semaglutide as CagriSema.

Amino Acid Derivative | Fatty Acid Transporter

L-Carnitine (levocarnitine) is an amino acid derivative that shuttles long-chain fatty acids into mitochondria for energy production, studied for metabolic, cardiovascular, and exercise performance applications.

Modified hGH Fragment | Fat Loss Peptide

A GH-fragment–derived peptide primarily discussed for fat loss and body-composition change, sometimes with cartilage and joint-repair context.

Dual GLP-1/Glucagon Receptor Agonist | Weight Loss & Diabetes

Mazdutide (IBI362) is an investigational dual GLP-1/glucagon receptor agonist studied for weight loss and type 2 diabetes, combining appetite suppression with increased energy expenditure.

NNMT Inhibitor | Longevity & Metabolic Enhancement

Research-peptide often discussed for body recomposition: weight-loss–focused with muscle preservation, cholesterol and inflammation effects.

5-Aminoimidazole-4-carboxamide Ribonucleotide | AMPK Activator

AICAR (Acadesine) is a small-molecule AMPK activator studied for metabolic, endurance, and cardioprotective effects. It mimics AMP to shift cells toward energy-producing pathways.

Stimulates GH release | Potential metabolic benefits

### Summary GH secretagogue blends are formulations designed to stimulate the secretion of growth hormone (GH) from the pituitary gland. These blends typically consist of various peptides and compounds that may enhance GH release, potentially influencing growth, metabolism, and overall health.

Lipolytic action | Fat loss

HGH Fragment 176–191, a GH-derived peptide discussed primarily for fat loss and bone/sleep effects.

Growth Hormone Fragment | Fat Loss Peptide

HGH Fragment 176-191 is a synthetic C-terminal fragment of human growth hormone studied for its lipolytic (fat-burning) effects without the growth-promoting actions of full GH.

Oral Small-Molecule GLP-1 Receptor Agonist | Weight Loss & Diabetes

Orforglipron (LY-3502970) is an investigational oral small-molecule GLP-1 receptor agonist studied for type 2 diabetes and obesity, offering pill-based dosing without injection.

KEDW Tetrapeptide | Pancreas Bioregulator

Pancragen (KEDW) is a synthetic tetrapeptide bioregulator studied for pancreatic endocrine support, glucose-insulin modulation, and longevity applications in preclinical and small human studies.

Four-Peptide Regenerative Blend

KLOW is a four-peptide compounded blend (typically KPV, LL-37, GHK, and Wolverine-style healing peptides) studied informally for combined regenerative and metabolic effects.

GLP-1 analog | Type 2 diabetes management

Research peptide discovered via AI researcher. peptide-based therapeutic

Melanocortin receptor agonist | Weight management

Research peptide discovered via AI researcher. peptide-based therapeutic

Mitochondrial function | Potential therapeutic

Research peptide discovered via AI researcher. peptide-based therapeutic

Glucose regulation | Diabetes management

Research peptide discovered via AI researcher. peptide-based therapeutic

GnRH Agonist | Hormone modulation

Research peptide discovered via AI researcher. peptide analogue

GLP-1 Agonist | Type 2 Diabetes Management

Research peptide discovered via AI researcher. peptide-based therapeutic

Water retention | Diabetes insipidus

Research peptide discovered via AI researcher. peptide-based therapeutic

GLP-1 Agonist | Type 2 Diabetes Management

Research peptide discovered via AI researcher. peptide-based therapeutic

Metabolic regulation | Potential role in glucose metabolism

Research peptide discovered via AI researcher. research peptide

Antidiuretic | Fluid balance regulation

Research peptide discovered via AI researcher. peptide-based therapeutic

GnRH Agonist | Hormone-sensitive conditions

Research peptide discovered via AI researcher. peptide analogue